期刊文献+

巨噬细胞自噬和极化在脓毒症发病机制中的研究进展 被引量:8

Research progress on macrophage autophagy and polarization in the pathogenesis of sepsis
原文传递
导出
摘要 脓毒症是由感染引起的全身炎症反应综合征,其核心机制是免疫功能紊乱。巨噬细胞具有极化、自噬、调节炎症反应和杀灭微生物的作用,是参与机体非特异性免疫的重要组成部分。研究发现,巨噬细胞可以通过极化、自噬等生物学行为在脓毒症的免疫调节中发挥重要作用。文章就巨噬细胞极化、自噬在脓毒症发病机制领域相关研究进展进行综述。调控巨噬细胞生物学行为有望成为未来脓毒症治疗的新靶点。 Sepsis is a systemic inflammatory syndrome caused by infection,with the core mechanism of immune dysfunction.Macrophages are involved in autophagy,phagocytosis,regulation of inflammatory response and killing microorganisms,and are an important element of non-specific immunity to the body.It has been found that macrophages play an important role in the immune regulation of sepsis through biological behaviors such as polarization and autophagy.The current paper summarized the research progress on macrophage polarization and autophagy in the pathogenesis of sepsis.Regulating macrophage biological behavior is expected to be a new target for the treatment of sepsis in the future.
作者 周璐璐 王雅菲 陈君 谢克亮 Zhou Lulu;Wang Yafei;Chen Jun;Xie Keliang(Department of Anesthesiology,Tianjin Huanhu Hospital,Tianjin Key Laboratory of Cerebral Vessels and Neural Degeneration,Tianjin 300350,China;Tianjin Medical University,School of Basic Medical Sciences,Tianjin 300070,China;Department of Anesthesiology,General Hospital of Tianjin Medical University,Tianjin Research Institute of Anesthesiology,Tianjin 300052,China;Department of Critical Care Medicine,General Hospital of Tianjin Medical University,Tianjin 300052,China;Translational Research Institute of Intensive Care Medicine,College of Anesthesiology,Weifang Medical University,Weifang 261053,China)
出处 《国际麻醉学与复苏杂志》 CAS 2022年第9期984-987,共4页 International Journal of Anesthesiology and Resuscitation
基金 国家自然科学基金(81971879,81772043) 天津市自然科学基金(17JCYBJC24800) 天津市科技计划项目重点研发计划科技支撑重点项目(18YFZCSY00560)。
关键词 脓毒症 巨噬细胞 自噬 极化 发病机制 Sepsis Macrophages Autophagy Polarization Pathogenesis
  • 相关文献

参考文献6

二级参考文献56

  • 1马兵,夏照帆.促/抗炎性细胞因子对外科脓毒症效应机制的研究进展[J].中华医学杂志,2005,85(41):2943-2947. 被引量:23
  • 2方向明,黄丽霞.脓毒症的分子遗传学研究进展[J].国际麻醉学与复苏杂志,2006,27(3):189-194. 被引量:3
  • 3Medzhitov R, Preston-Hurlburt P, Janeway C, et al. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature, 1997, 388(6640): 323-324.
  • 4Kim HM, Park BS, Kim JI, et al. Crystal structure of the TLR4- MD-2 complex with bound endotoxin antagonist Eritoran. Cell, 2007, 130(5): 906-917.
  • 5Akira S, Takeda K. Toll-like receptor signaling. Nat Rev Immunol, 2004, 4(7): 499-511.
  • 6Miggin SM, O'Neill LA. New insights into the regulation of signaling. J Leukoc Biol, 2006, 80(2): 220-226.
  • 7Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TLR4 gene. Science, 1998, 282(5396): 2085-2088.
  • 8Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol, 1999, 162(7): 3749-3752.
  • 9Smirnoval I, Hamblin MT, McBride C, et al. Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genetics, 2001, 158(4): 1657-1664.
  • 10Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet, 2000, 25(2): 187-191.

共引文献50

同被引文献64

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部